Cellectricon, AstraZeneca Extend Collaboration | GenomeWeb
NEW YORK (GenomeWeb News) – Cellectricon today said that it has signed a new agreement with AstraZeneca, under which the drug giant will use two of the firm’s DynaFlow HT platforms for ion channel screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.